On July 17, 2019, CVS Health announced the initiation of a clinical trial to evaluate the safety and efficacy of their at-home HemoCare™ Hemodialysis System for administration of home hemodialysis. The goal of the HemoCare™ Hemodialysis System is to clean a person’s blood more often than the typically thrice-weekly procedures performed in commercial clinics. The outcomes of the clinical trial will be submitted to the U.S. Food and Drug Administration (FDA) to obtain market clearance. The clinical trial of up to 70 individuals is being conducted at up to ten sites in the U.S. The . . .